4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000950170-24-062052
Chief Legal Officer and EVP sold 843 shares at $0.94 ($792)
- Chief Legal Officer and EVP acquired 2,656 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
DesRosier Thomas · Chief Legal Officer and EVP
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +2,656 | 123,233 | D | ||
| 2024-05-15 | Sale : show line 2 in the form 10b5-1 | −843 | $0.94 | $792 | 122,390 | D |
| Open-market sales · 843 sh · avg $0.94 · $792 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-05-15 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Units | −2,656 | 29,219 | D |
Loading xslF345X05/ownership.xml…